Business Description
AIM ImmunoTech Inc
NAICS : 325414
SIC : 2836
ISIN : US42366C3016
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 18.2 | |||||
Equity-to-Asset | 0.53 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -0.02 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -32.78 | |||||
Beneish M-Score | -7.56 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -7.2 | |||||
3-Year EBITDA Growth Rate | -16.9 | |||||
3-Year EPS without NRI Growth Rate | -10.1 | |||||
3-Year FCF Growth Rate | -9.4 | |||||
3-Year Book Growth Rate | -48.7 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 23.77 | |||||
9-Day RSI | 35.38 | |||||
14-Day RSI | 41.5 | |||||
6-1 Month Momentum % | 13.41 | |||||
12-1 Month Momentum % | -9.38 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.68 | |||||
Quick Ratio | 1.68 | |||||
Cash Ratio | 1.51 | |||||
Days Sales Outstanding | 1590.1 | |||||
Days Payable | 22112.05 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.2 | |||||
Shareholder Yield % | -2.77 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 79.21 | |||||
Operating Margin % | -15800.5 | |||||
Net Margin % | -14337.62 | |||||
FCF Margin % | -10473.94 | |||||
ROE % | -106.14 | |||||
ROA % | -91.19 | |||||
ROIC % | -616.3 | |||||
ROC (Joel Greenblatt) % | -2535.98 | |||||
ROCE % | -112.53 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 101.63 | |||||
PB Ratio | 2.1 | |||||
Price-to-Tangible-Book | 2.62 | |||||
EV-to-EBIT | -0.29 | |||||
EV-to-EBITDA | -0.29 | |||||
EV-to-Revenue | 44.4 | |||||
EV-to-Forward-Revenue | 3.64 | |||||
EV-to-FCF | -0.42 | |||||
Price-to-Median-PS-Value | 0.63 | |||||
Price-to-Net-Current-Asset-Value | 4.25 | |||||
Price-to-Net-Cash | 4.86 | |||||
Earnings Yield (Greenblatt) % | -344.83 | |||||
FCF Yield % | -103.08 |